Clayens Expands Micro-Injection Expertise with Bioresorbable Implants Following Acquisition of Providence Site (RI)
Clayens, a global leader in plastic injection molding and machining, has enhanced its micro-injection capabilities with the acquisition of the NP Providence site, near Boston in the USA. This strategic expansion has enabled the integration of a range of micro-implants, including those made from bioresorbable polymer (polylactid acid -PLA et polyglycolic acid - PGA). These devices are designed to dissolve in the body in a controlled manner, eliminating the need for subsequent surgical removal.
Among these implants, Clayens is manufacturing bioresorbable staples made from PGA/PLA used in nasal surgeries, which resorb within a few months. By replacing sutures, this system allows surgeons to place resorbable implants in less than a minute, reducing operation time and damage to surrounding tissues.
The site also manufactures an implant for spinal surgery. This implant utilizes another PGA/PLA grade to facilitate its resorption in the body: it enables rapid and effective closure of spinal incisions, reducing closure time and preventing leakage of cerebrospinal fluid, ensuring a safer and more effective procedure. This advancement in neurosurgery offers unprecedented efficiency while reducing costs and postoperative complications.
Equipment and Processes
The Providence site is equipped with purpose-made production capabilities including several 7-ton molding machines appropriately sized for the smallest applications and a clean room equipped with high magnification microscopes for in process inspection. These facilities enable the production of high-precision, high-quality devices that meet the stringent requirements of medical applications.
Will Johnson, who holds a masters in Plastics Engineering and has worked closely on micro-injection molding projects at the Providence site states: "These advanced processes used at our Providence site serve as a model for our US facilities and are replicable across all Clayens sites, including in Europe, demonstrating our commitment to innovation and operational excellence."
Similar to our Providence facility, several other Clayens sites across Europe, including NP Jura and NP Sud, specialize in the injection molding of small-scale technical parts. These sites ensure the production of high-precision devices, meeting the most stringent quality and performance standards.
We encourage any company or professional facing similar challenges to contact us. Our expertise and technology are at your disposal to turn your ideas into concrete and effective solutions.
About Clayens:
CLAYENS Healthcare, representing the healthcare activity of the CLAYENS Group, supports industrial health players (medical devices, pharmaceuticals, and diagnostics) in the development, industrialization, and manufacturing of custom medical devices and plastic components in compliance with international regulatory standards.
CLAYENS Healthcare offers a complete service, from R&D to production, including industrialization, qualification, validation, and regulatory support.
Present in 9 countries, the CLAYENS Group has nearly 5,000 employees and 32 manufacturing sites. The Group's 8 cleanrooms are located in France (ISO7), the USA (ISO8), and Mexico (ISO7).
More information: https://www.clayens.com/healthcare.
------
Contact us:
Brian FLYNN - Executive Vice President Clayens USA
+1 (347) 526-3019